This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
The Association for the Cannabinoid Industry (ACI), along with key industry stakeholders, has launched Green Bridge Gateway, a network of service providers for cannabis companies seeking to enter the UK and EU.
The UK has begun to regulate the market for orally consumed legal cannabis extracts, following the release of the Food Standards Agency’s public list of cannabidiol (CBD) products permitted for sale to consumers.
The Elixinol and British Cannabis agreement enables Elixinol’s brand to continue to be distributed in the UK, while handing over the UK operations and associated cost.
The Association for the Cannabinoid Industry and Centre for Medicinal Cannabis estimate the UK’s consumer cannabidiol (CBD) market will generate £690 million ($976 million) in annual sales in 2021.